Abstract:Background: Myocarditis occurs in acute Kawasaki disease (KD), and case series with endomyocardial biopsy report that KD patients (pts) may have myocardial fibrosis. The new cardiac magnetic resonance (CMR) technique of myocardial T1 measurement is a noninvasive means of measuring diffuse myocardial fibrosis. We sought to assess the prevalence and risk factors for diffuse myocardial fibrosis in KD pts using CMR. Methods: In this retrospective study, all pts with KD who had a CMR with extracellular volume fraction (ECV) measurement at Boston Children’s Hospital were included. The ECV, a measure of diffuse fibrosis, was calculated in the mid-left ventricle by measuring T1 values for blood pool and myocardium before and after gadolinium with a Look-Locker technique, and adjusting for hematocrit. Myocardium with focal fibrosis as evidenced by late gadolinium enhancement (LGE) was excluded. ECV results were compared to values from control subjects (n=20; median age 16 yrs (range, 11-36)) who had a normal CMR exam, and no history of left heart disease or cardiomyopathy. Results: Subjects (n=10) had a median age at CMR of 13 yrs (range, 8-36), median age at KD diagnosis of 3 yrs (0.3-11), and median time interval from diagnosis to CMR of 10 yrs (0.3-34). Nine pts had coronary aneurysms and the other 1 had mild left ventricular dysfunction. All 3 pts with a known history of myocardial infarction (MI) had a LGE pattern consistent with MI. LGE with a MI pattern was also seen in 1 additional pt without a history of MI but who had undergone coronary bypass surgery. Overall, ECV was not significantly different in KD pts and controls (0.25 ± 0.03 (range, 0.21-0.30) vs. 0.24 ± 0.03 (range, 0.18-0.28), p=0.29). One pt (10%) had an increased mean ECV (>0.28). ECV was not associated with indexed LV mass, mass/volume ratio, ejection fraction, or LGE. Conclusions: In this small pilot study of KD pts most of whom had aneurysms, diffuse myocardial fibrosis based on ECV did not differ significantly from that in normal control subjects, although 1 in 10 pts had an ECV above the normal range. Future larger studies should compare ECV in KD pts with and without aneurysms to define the risk of myocardial fibrosis after KD and to guide future recommendations for follow-up and therapy.

Recovery of myocardial mechanics in Kawasaki disease demonstrated by speckle tracking and tissue Doppler methods

Evaluation of myocardial deformation in children with Kawasaki disease by two dimensional speckle tracking echocardiography

Changes in CD_(69),CD_(25) and HLA-DR Expressions in Peripheral Blood T Cells in Kawasaki Disease

Tei Index Assessment of Left Ventricular Function in Patients with Kawasaki Disease

Assessment of Myocardial Function by Two-Dimensional Speckle Tracking Echocardiography in Patients with Kawasaki Disease: a Mid-Term Follow-Up Study.

Cardiac magnetic resonance feature tracking in Kawasaki disease convalescence

Left Atrial Subclinical Dysfunction in Children with Kawasaki Disease: a Two-Dimensional Speckle-Tracking Echocardiography Study.

Evaluation of Left Ventricnlar Systolic Function in Children at Acute Stage of Kawasaki Disease Using Speckie-Iracing Imaging

Left ventricular function assessment in Kawasaki disease by two-dimensional global longitudinal systolic strain with automated function imaging

Serial Exercise Testing and Echocardiography Findings of Patients With Kawasaki Disease

Performance of Cardiovascular Magnetic Resonance Strain in Patients with Acute Myocarditis

Evaluation of Cardiac Function by Magnetic Resonance Imaging During the Follow-Up of Patients With Kawasaki Disease

Successful non-invasive imaging of the coronary artery IMT in pediatric patients with Kawasaki disease using high-resolution echocardiography

Evaluation of heart function by strain rate imaging in children with Kawasaki disease

Quantitative Assessment of Myocardial Edema by MR T2 Mapping in Children With Kawasaki Disease

Left Ventricular Systolic Dyssynchrony in Patients with Kawasaki Disease: a Real-Time Three-Dimensional Echocardiography Study

Usefulness of real-time 3-dimensional echocardiography to identify and quantify left ventricular dyssynchrony in patients with Kawasaki disease.

Evaluation of myocardial function impairment using the Tei index in patients with Ka-wasaki disease

Abstract O.56: Myocardial Fibrosis in Patients with a History of Kawasaki Disease: a Pilot Study

[The Study of Vascular Lesion Using Ultrasound in Children with a History of Kawasaki Disease].

The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease